This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200401-066OCv1 170/2/167    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Borczuk, A. C. Articles by Powell, C. A. Search for Related Content PubMed PubMed Citation Articles by Borczuk, A. C. Articles by Powell, C. A.

Molecular Signatures in Biopsy Specimens of Lung Cancer

Department of Pathology, Department of Medicine, Department of Radiology, Department of Biomedical Informatics, and Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, New York

Correspondence and requests for reprints should be addressed to Charles A. Powell, M.D., Department of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, 630 W. 168th Street, Box 91, New York, NY 10032. E-mail: cap6{at}columbia.edu

Gene expression profiles of resected tumors may predict treatment response and outcome. We hypothesized that profiles derived from lung tumor biopsies would discriminate tumor-specific gene signatures and provide predictive information about outcome. Lung carcinoma specimens were obtained from 23 patients undergoing computed tomography-guided transthoracic biopsy or endobronchial brushing for undiagnosed nodules. Excess tissue was processed for gene profiling. We built class prediction models for lung cancer histology and for cancer outcome. The histology model used an F test to identify 99 genes that were differentially expressed among lung cancer subtypes. The histology validation set class prediction accuracy rate was 86%. The outcome model used the maximum difference subset algorithm to identify 42 genes associated with high risk for cancer death. The outcome training set class prediction accuracy rate was 87%. In conclusion, gene expression profiles of biopsy specimens of lung cancers identify unique tumoral signatures that provide information about tissue morphology and prognosis. The use of specimens acquired from lung biopsy procedures to identify biomarkers of clinical outcome may have application in the management of patients with lung cancer. The procedures are safe and feasible; the efficacy and utility of this strategy will ultimately be determined by prospective clinical trials.

Key Words: lung neoplasms • microarray analysis of gene expression • prognosis

This article has been cited by other articles:

				A. C. Borczuk, R. L. Toonkel, and C. A. Powell Genomics of Lung Cancer Proceedings of the ATS, April 15, 2009; 6(2): 152 - 158. [Abstract] [Full Text] [PDF]

				M. Skrzypski, E. Jassem, M. Taron, J. J. Sanchez, P. Mendez, W. Rzyman, G. Gulida, D. Raz, D. Jablons, M. Provencio, et al. Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung Clin. Cancer Res., August 1, 2008; 14(15): 4794 - 4799. [Abstract] [Full Text] [PDF]

				T. W. Corson, C. Q. Zhu, S. K. Lau, F. A. Shepherd, M.-S. Tsao, and B. L. Gallie KIF14 Messenger RNA Expression Is Independently Prognostic for Outcome in Lung Cancer Clin. Cancer Res., June 1, 2007; 13(11): 3229 - 3234. [Abstract] [Full Text] [PDF]

				A. Vachani, M. Nebozhyn, S. Singhal, L. Alila, E. Wakeam, R. Muschel, C. A. Powell, P. Gaffney, B. Singh, M. S. Brose, et al. A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma Clin. Cancer Res., May 15, 2007; 13(10): 2905 - 2915. [Abstract] [Full Text] [PDF]

				S. Dubey and C. A. Powell Update in Lung Cancer 2006 Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 868 - 874. [Full Text] [PDF]

				D. N. Hayes, S. Monti, G. Parmigiani, C. B. Gilks, K. Naoki, A. Bhattacharjee, M. A. Socinski, C. Perou, and M. Meyerson Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts J. Clin. Oncol., November 1, 2006; 24(31): 5079 - 5090. [Abstract] [Full Text] [PDF]

				G. J. Gordon, L. A. Deters, M. D. Nitz, B. C. Lieberman, B. Y. Yeap, and R. Bueno Differential diagnosis of solitary lung nodules with gene expression ratios J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 621 - 627. [Abstract] [Full Text] [PDF]

				B. D. Grigoriu, F. Depontieu, A. Scherpereel, D. Gourcerol, P. Devos, T. Ouatas, J.-J. Lafitte, M.-C. Copin, A.-B. Tonnel, P. Lassalle, et al. Endocan Expression and Relationship with Survival in Human Non-Small Cell Lung Cancer Clin. Cancer Res., August 1, 2006; 12(15): 4575 - 4582. [Abstract] [Full Text] [PDF]

				M. P. Gruber, C. D. Coldren, M. D. Woolum, G. P. Cosgrove, C. Zeng, A. E. Baron, M. D. Moore, C. D. Cool, G. S. Worthen, K. K. Brown, et al. Human Lung Project: Evaluating Variance of Gene Expression in the Human Lung Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 65 - 71. [Abstract] [Full Text] [PDF]

				A. C. Borczuk, H. K. Kim, H. A. Yegen, R. A. Friedman, and C. A. Powell Lung Adenocarcinoma Global Profiling Identifies Type II Transforming Growth Factor-{beta} Receptor as a Repressor of Invasiveness Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 729 - 737. [Abstract] [Full Text] [PDF]

				T. D. Bradley, Y. E. Miller, F. J. Martinez, D. C. Angus, W. MacNee, and E. Abraham Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-disordered Breathing in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 675 - 685. [Full Text] [PDF]

				C. A. Granville and P. A. Dennis An Overview of Lung Cancer Genomics and Proteomics Am. J. Respir. Cell Mol. Biol., March 1, 2005; 32(3): 169 - 176. [Abstract] [Full Text] [PDF]

				D. Cross and J. K. Burmester The Promise of Molecular Profiling for Cancer Identification and Treatment Clin. Med. Res., August 1, 2004; 2(3): 147 - 150. [Full Text] [PDF]